OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
2.050
+0.010 (0.49%)
At close: Jan 30, 2026, 4:00 PM EST
2.041
-0.009 (-0.44%)
After-hours: Jan 30, 2026, 7:56 PM EST
OKYO Pharma Market Cap
OKYO Pharma has a market cap or net worth of $77.1 million as of January 30, 2026. Its market cap has increased by 125.61% in one year.
Market Cap
77.10M
Enterprise Value
73.07M
1-Year Change
125.61%
Ranking
Category
Stock Price
$2.05
Market Cap Chart
Since the IPO on September 4, 2013, OKYO Pharma's market cap has decreased from $141.20M to $77.10M, a decrease of -45.39%. That is a compound annual growth rate of -4.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 77.10M | -0.97% |
| Dec 31, 2025 | 77.85M | 100.10% |
| Dec 31, 2024 | 38.91M | -33.86% |
| Dec 29, 2023 | 58.83M | 38.58% |
| Dec 20, 2022 | 42.45M | -48.55% |
| Dec 10, 2021 | 82.51M | 4.85% |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coeptis Therapeutics Holdings | 78.61M |
| PolyPid | 78.05M |
| Pelthos Therapeutics | 77.75M |
| Pliant Therapeutics | 76.50M |
| Annovis Bio | 75.40M |
| Gain Therapeutics | 75.39M |
| Atossa Therapeutics | 74.92M |
| Immunic | 71.45M |